Merck KGaA's expanded AI deal; Ascletis has new biomarker data for its PD-L1; Deka closes $20M round
Merck KGaA continues AI-powered deal streak: Merck KGaA has expanded its collaboration with Israeli company Quris-AI, with an eye to identifying …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.